You have 9 free searches left this month | for more free features.

Condition

Carcinoma, Squamous Cell (1)

Ovarian Cancer (1)

Squamous Cell Carcinoma of the Head and Neck (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Celgene (2)

Ludwig Institute for Cancer Research (1)

Collaborator

Cancer Research Institute, New York City (1)

Celgene (1)

MedImmune LLC (1)

Intervention

motolimod (2)

nivolumab (2)

cetuximab (1)

durvalumab (1)

pegylated liposomal doxorubicin (1)

vtx-2337 (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

Motolimod

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ovarian Cancer Trial in Switzerland, United States (Durvalumab, Pegylated Liposomal Doxorubicin, Motolimod)

Completed

Has Results

Ovarian Cancer

Durvalumab
+2 more

Phoenix, Arizona
+4 more

Aug 9, 2021

Carcinoma, Squamous Cell Trial in United States (VTX-2337, Nivolumab)

Completed

Carcinoma, Squamous Cell

Birmingham, Alabama
+6 more

Feb 23, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Motolimod, Cetuximab, Nivolumab)

Terminated

Squamous Cell Carcinoma of the Head and Neck

Motolimod
+2 more

Pittsburgh, Pennsylvania

University of Pittsburgh Medical Center

Oct 23, 2019